
Resident @MSHSDerm | MD, PhD @ColumbiaMed | @WilliamsCollege '16 | science, music, and fresh produce lover
Joined December 2020
- Tweets27
- Following74
- Followers55
- Likes80
Tricia Ho retweeted
New proof-of-concept study published today in @NatureBiotech led by @zwalsh96 from the @BizarMd lab demonstrates the superpower potential of changing only a single letter in the DNA code of selected genes in T cells to improve cell therapy. cancer.columbia.edu/news/imp…
Very honored to be receiving the Titus M. Coan Prize for Excellence in Translational Biology Research from Columbia GSAS at commencement! Thank you as always to my mentor @BizarMd ☺️ Fun fact: Titus Coan was also a Williams alum before he went to Columbia for med school!
Tricia Ho retweeted
Interested in T cell biology? Cellular immunotherapies? Base editing? And an amazing example for scientific reproducibility- this @biorxivpreprint & tweetorial are for you! TL:DR- we made primary human T cells better cancer killers! biorxiv.org/content/10.1101/…
Tricia Ho retweeted
Happy to share our latest paper! Was such a pleasure to help finalizing this work, which Chong and I started long time ago in @Schumacher_lab . Congrats to everyone involved! cell.com/cancer-cell/fulltex…
Tricia Ho retweeted
Online Now: The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity dlvr.it/SqyWXh
Tricia Ho retweeted
Thanks @Cancer_Cell for sharing, and grateful to reviewers and @Montse_Rojo_PhD for a constructive, engaging and fair review/revision process. Hard work by @triciahoho @JCA_Melms @meri_rogava with a product we are proud of.
Online Now: The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity dlvr.it/SqyWXh
My first first-author pub is finally out in @Cancer_Cell! Endless thanks to @BizarMd @JCA_Melms and @meri_rogava for all their guidance scientifically and personally that made this happen. Tweetorial below from our pre-print for now! authors.elsevier.com/c/1hFn3…
Very excited to share new work from the lab dissecting mechanisms of cancer immune evasion. True team effort led by MD/PhD student @triciahoho and post-docs @JCA_Melms @meri_rogava 1/14
biorxiv.org/content/10.1101/…
Tricia Ho retweeted
We have openings for multiple funded positions in the lab:
1. Molecular post-doc
2. Computational post-doc
3. Research technician(s) Check out our new website izarlab.com or connect with me via [email protected]
So proud of @meri_rogava, whom I am very lucky to call a friend and @BizarMd labmate, for her excellent talk at #AACR2023 !! Congrats Meri! 🎉🎉
Tricia Ho retweeted
Today the Ager Lab at @MayoClinic officially opened its doors! So thrilled to start this adventure, and thankful to friends and mentors that helped me get here.
I’m recruiting at all levels, so please RT to spread the word! More info at our website:
AgerLab.com
Grateful to be given the opportunity to present virtually this morning (extra early, NYC time!) at the @SocietyMelanoma #2022congress taking place in Edinburgh! Wish I could be there in person, and thanks as always to @BizarMd and labmates @meri_rogava and @JCA_Melms #smr2022
Tricia Ho retweeted
Very grateful - all the credit goes to my lab, especially @JCA_Melms and @triciahoho. This award will support some of our highest risk research!
This quoted post is unavailable.
Got to present some of my PhD research at #AACR2022 yesterday! Thanks to everyone who came to watch, and special shout out to my mentor @BizarMd and also @JCA_Melms @meri_rogava for helping me get to this point ☺️
Ecstatic to share my first first-author pre-print! Much thanks to my mentor @BizarMd and my wonderful co-authors @JCA_Melms and @meri_rogava. Very fun to make my dreams of studying cancer immunotherapy come true! biorxiv.org/content/10.1101/…
Tricia Ho retweeted
Very excited to share new work from the lab dissecting mechanisms of cancer immune evasion. True team effort led by MD/PhD student @triciahoho and post-docs @JCA_Melms @meri_rogava 1/14
biorxiv.org/content/10.1101/…
Tricia Ho retweeted
Two studies showing the power of multi-modal single-cell screens in the immuno-oncology field.
@satijalab studying regulators of PD-L1 go.nature.com/3dZamho
Our study studying mechanisms of immune evasion in patient models:
📢Out today in @NatureGenet from @BizarMd Aviv Regev and colleagues:
Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion | go.nature.com/3b9P2nD
Tricia Ho retweeted
congratulations to the whole team: @JCA_Melms @FrangiehChris @pratiktac @Gschuller_k @triciahoho and Aviv Regev. @columbiacancer @Columbia @CCTI_NYC
















